This IDTechEx report on diabetes management technologies and markets covers the entire landscape of medical devices, including mature, emerging and future options. The report discusses key technologies and companies in electrochemical glucose test strips, continuous glucose monitoring, insulin pens, insulin pumps, automated insulin delivery. Progress in emerging technologies such as non-invasive glucose monitoring is also discussed in the report. This IDTechEx report contains historical market data and ten-year market forecasts across four key product categories to 2035.

 

The diabetes management device market has seen major changes over the past decade. At the center is the shift from electrochemical glucose test strips that require fingers to be pricked towards minimally invasive continuous glucose monitors (CGMs). The multibillion-dollar test strip industry has been in steady decline since the 2010s while the CGM companies have experienced consistent growth. IDTechEx predicts that by 2035, annual revenues from glucose test strips will only make up 5.15% of the total market for diabetes management devices.

Glucose sensors: Past, present, and future

People with diabetes have historically used glucose test strips to monitor their blood glucose levels. The glucose testing market was valued at over US$7.8 billion in 2010, and was based on a high margin, razor blade business model. However, a combination of pricing pressures, more stringent reimbursement policies, and the shift of users to CGMs have been driving the decline of the test strip industry. Combined, these factors have resulted in former blood glucose testing market leaders divesting their diabetes divisions, and a shift of market share to players in East Asia.

 

On the other hand, the CGM market has seen rapid growth over the past decade. IDTechEx estimates a CAGR of 30% between 2015 and 2025. The shift from discrete to continuous monitoring is expected to continue over the next ten years, including expanding reimbursement around the world to include people with type 2 diabetes. In this report we discuss the outlook for both the glucose test strip market and CGM market going forward, along with ten-year market forecasts.

 

Insulin delivery: Progress towards closing the loop

Insulin delivery is the other half of the diabetes management market. Currently, for most people with diabetes, insulin is delivered using insulin pens. Over the next ten years, IDTechEx expects more people to shift from using insulin pens towards insulin pump therapy. Key drivers of this include new insulin pumps coming to market, new form factors such as the insulin patch pump, and the advancement of insulin delivery algorithms (and integration with CGMs). The further development of insulin delivery algorithms, and automated insulin delivery (AID) systems, will be key to the insulin pump market.

Digital health: Expansion of CGM into type 2 diabetes

Digital health plays a central role in diabetes management. Today, the advancement of connected medical devices such as CGMs, insulin pumps, and connected glucometers and smart insulin pens are enabling a wealth of data to be analyzed and shared online. In addition to easing some of the burden of diabetes management, digital health can provide context and education to people with diabetes. For example, a connected insulin pen, when combined with a CGM, can help users see the impact of each insulin dose on their blood glucose. Similarly, the expansion of CGMs into the consumer, prediabetes and type 2 diabetes markets will provide insight into how user's food and lifestyle choices impact their blood glucose levels.

 

Diabetes management device market analysis and forecasts

The glucose sensing and insulin delivery industries are highly interlinked - developments within one industry cause significant effects on others. IDTechEx have analyzed the entire market to produce a cohesive story, tying together developments and future milestones across the diabetes management industry to provide a realistic forecast of each individual market.

 

This report analyzes the technological and competitive landscapes of diabetes management, identifying and reviewing over 100 companies ranging from industry leaders to startups. It identifies key players in each sector along with partnerships across several industries.